Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
49.00
-0.13 (-0.26%)
Feb 18, 2026, 10:01 AM EST
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of $218.82 billion as of February 18, 2026. Its market cap has decreased by -41.74% in one year.
Market Cap
218.82B
Enterprise Value
235.26B
Revenue
48.59B
Ranking
n/a
PE Ratio
13.59
Stock Price
$49.00
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 218.82B, an increase of 2,961.94%. That is a compound annual growth rate of 12.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 218.82B | -3.87% |
| Dec 30, 2025 | 227.63B | -41.00% |
| Dec 30, 2024 | 385.82B | -16.41% |
| Dec 29, 2023 | 461.55B | 51.61% |
| Dec 30, 2022 | 304.43B | 19.34% |
| Dec 30, 2021 | 255.09B | 56.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 791.42M |
| Veradigm | 731.05M |
| Glass House Brands | 643.62M |
| Elite Pharmaceuticals | 473.83M |
| American Oncology Network | 389.18M |
| Northwest Biotherapeutics | 383.25M |
| OpGen | 365.23M |
| CytoDyn | 308.63M |